Document is current
Any future updates will be listed below
-
Authors
Abikenari, Matthew
Liu, Justin
Ha, Joseph H.
Annagiri, Shreyas
Himic, Vratko
Medikonda, Ravi
Kim, Lily
Choi, John
Lim, Michael
- License Information
-
More Information
Article History
Received: 1 May 2025
Accepted: 12 July 2025
First Online: 22 July 2025
Declarations
:
: Michael Lim: On the Journal’s Editorial Board and (Funding from Arbor Pharmaceuticals, Accuray, BMS, Novartis; Consultant: BMS, Merck, SQZ Biotechnologies, Tocagen, VBI; Patents: Combining Focused Radiation and Immunotherapy, Combining Local Chemotherapy and Immunotherapy; Shareholder: Egret Therapeutics).
: No pertinent conflicts of interest relevant to this manuscript.
